🖼

FIGURE 4 — The extracellular matrix component perlecan/HSPG2 regulates radioresistance in p

active
paper figure Created: 2026-04-21T18:29:40 By: paper_figures_tool Quality: 50% 🔗 External ID: paper-fig-paper-de0f65fde5fe-4
FIGURE 4 — The extracellular matrix component perlecan/HSPG2 regulates radioresistance in p
FIGURE 4Figure 4
Radiobiological colony formation assay (CFA). (A) CFA for the DU145 parental (P) cells after siRNA-mediated knockdown of HSPG2, LOXL2, LAMB3, or SRPX. Cells transfected with scrambled (Scr) siRNA were used as controls. Data are mean ± SD; * p < 0.05; *** p < 0.001. (B) CFA for the DU145 radioresistant (RR) cells after siRNA-mediated knockdown of HSPG2, LOXL2, LAMB3, or SRPX. Cells transfected with scrambled siRNA (Scr siRNA) were used as controls. Data are mean ± SD; * p < 0.05; *** p < 0.001.
PubMed: paper-de0f65fde5fe
Metadata
pmidpaper-de0f65fde5fe
captionRadiobiological colony formation assay (CFA). (A) CFA for the DU145 parental (P) cells after siRNA-mediated knockdown of HSPG2, LOXL2, LAMB3, or SRPX. Cells transfected with scrambled (Scr) siRNA we
image_urlhttps://www.ebi.ac.uk/europepmc/articles/PMC11325029/bin/fcell-12-1452463-g004.jpg
paper_titleThe extracellular matrix component perlecan/HSPG2 regulates radioresistance in prostate cancer cells.
figure_labelFIGURE 4
figure_number4
_schema_version1
source_strategypmc_api
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.